Geminus Therapeutics is developing Artemisinin (ART714) for treating leukemia.
Geminus Therapeutics Headquarter Location
Baltimore, Maryland,
United States
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
CB Insights uses Cookies
CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.